摘要
背景:感光细胞死亡是一个关键的视网膜变性疾病的病理学。到目前为止,这个病理过程的分子机制在很大程度上仍不清楚。交叉的附着力c分子(Jam-c)已经被证明能够扮演重要的角色在不同的生物事件。然而,它对视网膜神经细胞的影响是未知的。 目的:确定Jam-c对成年老鼠的眼睛,特别是在视网膜结构、血管和感光细胞,为了探索潜在的眼部疾病的重要目标分子。 方法:Jam-c全球基因敲除小鼠,endothelial-specific neuronal-specific Jam-c条件基因敲除小鼠使用Tie2-Cre和Nestin-Cre小鼠分别被用于这项研究。老鼠的眼睛是收获从不同群体和眼睛的尺寸检查。Cryosections的眼睛和苏木精和伊红染色())和视网膜层的厚度测量。分析了视网膜血管和锥杆光感受器使用isolectin B4,花生凝集素和视紫红质分别标记。在老鼠体内Jam-c击倒的眼睛是由intravitreal注入Jam-c成分。Jam-c表达式在视网膜感觉被实时PCR量化。 结果:全球Jam-c老鼠基因缺失导致小眼睛,减少镜片的直径和虹膜。Jam-c - / -小鼠显示显著变薄的外核层(筒),数量少的感光细胞,视网膜血管异常。重要的是,neuronal-specific Jam-c删除导致相似的表型,而没有明显的缺陷在endothelial-specific Jam-c基因敲除小鼠。此外,Jam-c击倒的成分也减少了辊筒厚度和感光数字。 结论:我们发现Jam-c至关所需的正常大小和视网膜结构。特别是Jam-c扮演重要的角色在维持正常的视网膜厚度、血管和感光号码。因此Jam-c因此可能在各种眼部疾病有重要的作用。
关键词: 交叉的附着力c分子、视网膜光感受器变性
Current Molecular Medicine
Title:Neuronal Expression of Junctional Adhesion Molecule-C is Essential for Retinal Thickness and Photoreceptor Survival
Volume: 17 Issue: 7
关键词: 交叉的附着力c分子、视网膜光感受器变性
摘要: Background: Photoreceptor cell death is a key pathology of retinal degeneration diseases. To date, the molecular mechanisms for this pathological process remain largely unclear. Junctional adhesion molecule-c (Jam-c) has been shown to play important roles in different biological events. However, its effect on retinal neuronal cells is unknown.
Objective: To determine the effect of Jam-c on adult mouse eyes, particularly, on retinal structure, vasculature and photoreceptor cells, in order to explore potential important target molecules for ocular diseases.
Methods: Jam-c global knockout mice, endothelial-specific and neuronal-specific Jam-c conditional knockout mice using Tie2-Cre and Nestin-Cre mice respectively were used in this study. Mouse eyes were harvested from the different groups and eye size examined. Cryosections of the eyes were made and stained with Hematoxylin and Eosin (H&E) and the thicknesses of retinal layers measured. Retinal blood vessels and cone and rod photoreceptors were analyzed using isolectin B4, peanut agglutinin and rhodopsin as markers respectively. In vivo Jam-c knockdown in mouse eyes was performed by intravitreal injection of Jam-c shRNA. Jam-c expression in the retinae was quantified by real-time PCR.
Results: Global Jam-c gene deletion in mice resulted in smaller eyes and decreased the diameters of lens and iris. Jam-c-/- mice display marked thinning of the outer nuclear layer (ONL), less numbers of photoreceptor cells, and abnormal retinal vasculature. Importantly, neuronal-specific Jam-c deletion led to similar phenotype, whereas no obvious defect was observed in endothelial-specific Jam-c knockout mice. Moreover, Jam-c knockdown by shRNA also decreased ONL thickness and photoreceptor numbers.
Conclusion: We found that Jam-c is critically required for the normal size and retinal structure. Particularly, Jam-c plays important roles in maintaining the normal retinal thickness, vasculature and photoreceptor numbers. Jam-c thus may therefore have important roles in various ocular diseases.
Export Options
About this article
Cite this article as:
Neuronal Expression of Junctional Adhesion Molecule-C is Essential for Retinal Thickness and Photoreceptor Survival, Current Molecular Medicine 2017; 17 (7) . https://dx.doi.org/10.2174/1566524018666180212144500
DOI https://dx.doi.org/10.2174/1566524018666180212144500 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Myelodysplastic Syndromes: Review of Pathophysiology and Current Novel Treatment Approaches
Current Cancer Drug Targets Insulin-Degrading Enzyme: A Link Between Alzheimer’s and Type 2 Diabetes Mellitus
CNS & Neurological Disorders - Drug Targets Could Additional Inhibitors of the Renin -Angiotensin System be Clinically Useful?
Current Hypertension Reviews The Chick Embryo Chorioallantoic Membrane as a Model for in vivo Research on Anti-Angiogenesis
Current Pharmaceutical Biotechnology Preparation of Hymenialdisine, Analogues and Their Evaluation as Kinase Inhibitors
Current Medicinal Chemistry Role of Human and Mouse HspB1 in Metastasis
Current Molecular Medicine Alkynes as Privileged Synthons in Selected Organic Name Reactions
Current Organic Synthesis Indazolo[3,2-b]quinazolinones Attack Hepatocellular Carcinoma Hep3B Cells by Inducing Mitochondrial-Dependent Apoptosis and Inhibition of Nrf2/ARE Signaling Pathway
Current Molecular Medicine Chemistry and Health Effects of Bioactive Compounds in Selected Culinary Aromatic Herbs
Current Nutrition & Food Science HPMC- A Marvel Polymer for Pharmaceutical Industry-Patent Review
Recent Advances in Drug Delivery and Formulation Flavonoids, Vascular Function and Cardiovascular Protection
Current Pharmaceutical Design Angiogenic and Antiangiogenic Factors in Proliferative Diabetic Retinopathy
Current Diabetes Reviews Beneficiary and Adverse Effects of Phytoestrogens: A Potential Constituent of Plant-based Diet
Current Pharmaceutical Design RNA-Based Gene Therapy for Haemophilia B
Current Genomics An International Education Partnership: Duke-NUS Graduate Medical School at 10 Years
Applied Clinical Research, Clinical Trials and Regulatory Affairs Lipid-Based Nanoparticles as Carriers for Dermal Delivery of Antioxidants
Current Drug Metabolism Editorial (Personalized Medicine in the Age of Pharmacoproteomics: A Close up on India and Need for Social Science Engagement for Responsible Innovation in Post-Proteomic Biology)
Current Pharmacogenomics and Personalized Medicine Design of Magnetic Nanoparticles-Assisted Drug Delivery System
Current Pharmaceutical Design Clinical Experience with Thalidomide and Lenalidomide in Multiple Myeloma
Current Cancer Drug Targets Self-Assembling Peptide Nanofibrous Hydrogel as a Versatile Drug Delivery Platform
Current Pharmaceutical Design